The European Master's in Clinical Linguistics (EMCL) is an Erasmus Mundus Joint Master Degree (EMJMD) that has been running for over 20 years. The newest edition is offered by the universities of Ghent (Belgium), Groningen (The Netherlands) and Eastern Finland (Finland). We also collaborate with 26 excellent associated partners.
At the University of Groningen the emphasis is on crosslinguistic studies of language-impaired children and adults, language testing in neurosurgical settings, and the usage of neurotechnology and IT for the diagnosis and treatment of language impairments. At Ghent University students are familiarized with advanced topics in statistics and psycholinguistics, including bilingualism, dyslexia, and eye tracking. Finally, at the University of Eastern Finland, the main focus is on speech technology and programming with Python, including both fundamental theory and methods, as well as their application to the assessment of, and adaptive solutions for, speech impairments.
In addition, we have the support of 26 associated partners, of which 12 are in the academic sector, 5 in R&D/neurotechnology, and 9 in the clinical sector - for further details, see this overview.
In every cohort, we welcome about twenty students from all over the world. Over two years, our students receive training at each of the academic partners, do a compulsory internship at one of the associated partners, and write an original master’s thesis. Thereafter, 70% of our students continue to do research in PhD programmes. Furthermore, since 2017, we are seeing an increase in alumni who pursue R&D and clinical work, making our programme competitive in the international market.